Portside Wealth Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1978608 Provo, UT

Position in GILD

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$1,951,826

-$225,133 QoQ

Shares Held

15,449

-1.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#840

of 2,266 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Portside Wealth Group, LLC holds $35,072,554 across 13 Drug Manufacturers - General names. GILD ranks #7 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	28,497	$7,237,382
2	LLY	ELI LILLY & Co	5,720	$6,860,739
3	ABBV	AbbVie Inc.	17,712	$4,457,047
4	NVO	Novo Nordisk A S	76,258	$3,655,808
5	MRK	Merck & Co., Inc.	21,032	$2,702,612
6	PFE	Pfizer Inc	89,045	$2,144,203
7	GILD	Gilead Sciences, Inc. This page	15,449	$1,951,826
8	NVS	Novartis AG	12,409	$1,944,738

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,951,826	15,449	-1.1%	Shares	Other	2026-07-14
2026-03-31	$2,176,959	15,620	-6.7%	Shares	Sole	2026-05-12
2025-12-31	$2,055,894	16,750	-5.6%	Shares	Sole	2026-01-21
2025-09-30	$1,969,251	17,741	+1.6%	Shares	Other	2025-11-05
2025-06-30	$1,935,235	17,455	+3.7%	Shares	Other	2025-08-11
2025-03-31	$1,886,249	16,834	+2.3%	Shares	Sole	2025-04-14
2024-12-31	$1,520,502	16,461	-5.4%	Shares	Other	2025-04-14
2024-09-30	$1,459,401	17,407	+11.7%	Shares	Sole	2024-10-31
2024-06-30	$1,068,943	15,580	-3.2%	Shares	Other	2024-07-18
2024-03-31	$1,178,885	16,094	-1.9%	Shares	Other	2024-04-17
2023-12-31	$1,329,374	16,410	+79.4%	Shares	Other	2024-01-16
2023-09-30	$685,551	9,148	+0.9%	Shares	Other	2023-10-27
2023-06-30	$699,024	9,070	—	Shares	Other	2023-09-01
No filing history on record for this holder in this stock.